Proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) laser technology provide lower-cost, faster-deploy alternatives to gas centrifuges for isotope enrichment — producing HALEU nuclear fuel (150 MT / 10-year TerraPower supply agreement from 2028), Silicon-28 for quantum computing/semiconductors, Ytterbium-176 for Lu-177 medical isotopes, and helium via the Renergen/Virginia Gas Project acquisition. Three enrichment facilities now operational in South Africa.
Conviction●●●○○3 of 5
Research target8.76Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed 6/22/26
Market cap888.88MSnapshot value
1) Silicon-28 commercial shipments targeted Q3 2026 — Pretoria facility restart completed May/June 2026; first 18 enrichment stages now operational. 2) Helium business spinoff/merger into NOBA (new Nasdaq entity) — ASPI to retain ~89% majority ownership; take-or-pay contracts at premium pricing >00/MCF. 3) TerraPower HALEU supply agreement — up to 150 metric tons over 10 years starting 2028, supporting Natrium reactor deployment.
1) Execution risk on scaling proprietary enrichment tech — ASP and QE are unproven at commercial scale vs established gas centrifuge incumbents; technical setbacks could delay revenue ramp. 2) Capital intensity and dilution risk — multiple large capital raises in 2025-2026; ongoing cash consumption until HALEU revenue materializes 2028+. 3) Nuclear regulatory delays (NRC, DOE licensing) or policy shifts that slow/block HALEU fuel qualification and advanced reactor deployment.
Strongly bullish on X — described as multi-bagger, next LEU comparison, 98% concentrated retail positions, strong dip-buying at .88-.00 support. CEO interviews and operational updates widely shared. Reddit was skeptical earlier 2026 but sentiment shifting positive on Si-28 restart and helium contracts. Short interest noted but not extreme squeeze territory. Market cap ~00-800M. Sentiment: Bullish.
Snapshot · 6/22/26🟢 Lean-Bull · ins-$4.9M · 13F 15+/7- · short↑0.24
Snapshot · 6/22/26